Skip to Main Content Skip to Site Map Skip to Accessibility Statement
Home Formulary 4.0 Central Nervous System 4.9 Drugs used in parkinsonism and related disorders 4.9.1 Dopaminergic drugs used in parkinsonism 4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors)

4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors)

ChoiceDrugDosage
1st choiceEntacapone tablets 200mgDose:
See BNF - seek specialist advice
2nd choiceOpicapone 50mg capsules


Or

Tolcapone 100mg tablets 		Dose:
See BNF - seek specialist advice


Dose:
See BNF and Shared Care Guideline- seek specialist advice as per notes below

Prescribing Notes

  • A triple combination preparation of levodopa, carbidopa and entacapone may be suitable for patients requiring entacapone who are having problems with concordance. Prescribe by brand – Sastravi® and Stanek®  are currently the ‘branded generic’ combination preparations with the lowest acquisition cost.
  • Due to the risk of hepatotoxicity, tolcapone should be prescribed under specialist supervision only, when other COMT inhibitors combined with co-beneldopa or co-careldopa are ineffective or not tolerated. LFT monitoring is required (see shared care guideline).
  • The levodopa dose may need to be adjusted when a COMT inhibitor is initiated.
  • Tolcapone should only be continued beyond three weeks if there is substantial improvement in symptom control.

Quick Links